Literature DB >> 5535446

[Is proinsulin contamination of commercial insulin preparations responsible for the stimulation of insulin antibodies?].

L Kerp, S Steinhilber, H Kasemir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5535446     DOI： 10.1007/bf01583916

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  3 in total

1.  [Bovine proinsulin: isolation, properties and activation by trypsin].

Authors:  D D Schmidt; A Arens
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1968-09

2. 

Authors:  L Kerp; S Steinhilber; D D. Schmidt
Journal:  FEBS Lett       Date:  1970-06-01       Impact factor: 4.124

3.  Isolation and properties of proinsulin, intermediate forms, and other minor components from crystalline bovine insulin.

Authors:  D F Steiner; O Hallund; A Rubenstein; S Cho; C Bayliss
Journal:  Diabetes       Date:  1968-12       Impact factor: 9.461
  3 in total
  5 in total

1.  [Study on the purity of commercially available insulin-preparations using discontinuous polyacrylamide gel electrophoresis].

Authors:  T O Tjioe; A Wacker
Journal:  Klin Wochenschr       Date:  1972-09-15

2.  The glomerular basement membrane of the rabbit kidney on long-term treatment with heterologous insulin preparations of different purity.

Authors:  H Wehner; H Huber; K H Kronenberg
Journal:  Diabetologia       Date:  1973-08       Impact factor: 10.122

3.  Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia.

Authors:  J Goldman; D Baldwin; A H Rubenstein; D D Klink; W G Blackard; L K Fisher; T F Roe; J J Schnure
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

4.  Quantitative morphological analysis of glomerular changes of the rabbit kidney on treatment with insulin preparations of different purity.

Authors:  H Wehner; B Schober; R Dieterich
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-06-23

5.  Antibody formation and insulin requirements in diabetic children during treatment with purified commercial pork insulins.

Authors:  B Weber; J Tech; H Schmidt; U Oberdisse
Journal:  Eur J Pediatr       Date:  1978-06-20       Impact factor: 3.183
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.